Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 1Phase 3 1Phase 2 1

Status

Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Breast Neoplasms 395Neoplasms 338Prostatic Neoplasms 189Lung Neoplasms 176Colorectal Neoplasms 143Motor Activity 88Uterine Cervical Neoplasms 75Pancreatic Neoplasms 74Head and Neck Neoplasms 70Brain Neoplasms 69Carcinoma, Non-Small-Cell Lung 64Ovarian Neoplasms 60Carcinoma, Hepatocellular 51Rectal Neoplasms 49Colonic Neoplasms 46Glioblastoma 42Anxiety Disorders 41Precursor Cell Lymphoblastic Leukemia-Lymphoma 40Neoplasm Metastasis 40Depression 39Hematologic Neoplasms 38Glioma 36Melanoma 35Stomach Neoplasms 33Multiple Myeloma 33Disease 33Sarcoma 31Carcinoma, Renal Cell 31Urinary Bladder Neoplasms 30Pain 28

Interventions

Ultrasonic Waves 1Standard of Care 1Educational Status 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Opioid-Related Disorders × 90 days × Clear all
NCT07451197 2026-05-11

Family-Focused Study to Support Medication for Opioid Use Disorder

University of Wisconsin, Madison

Phase NA Not yet recruiting
338 enrolled
Lymphoid

Lymphoma, Follicular, Opioid-Related Disorders

NCT04921787 2026-04-23

EXHITENTRE

Hennepin Healthcare Research Institute

Phase NA Active not recruiting
24 enrolled
Lymphoid

Lymphoma, Follicular, Opioid-Related Disorders, Substance-Related Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡